[{"Name": "JohnHuber72", "Time": "20190716", "Text": "@ojaz12 @afc The huge returns have mostly come from revenue growth. SHOP\u2019s multiple is only 1.33x higher than IPO,\u2026 https://t.co/esOp1mdwVI"}, {"Name": "JohnHuber72", "Time": "20190716", "Text": "@oddballstocks Hmmm... I didn\u2019t really see that at all Nate. He was just laying out facts on the historical perform\u2026 https://t.co/SpmOoRxELp"}, {"Name": "JohnHuber72", "Time": "20190716", "Text": "@ojaz12 @afc I think the question for SaaS industry generally is what do normal economics look without VC subsidies\u2026 https://t.co/fKhgWvX2LJ"}, {"Name": "FundyLongShort", "Time": "20190716", "Text": "@WTCM3 Excellent, thanks for posting."}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "We\u2019re short $CDNA. Report available at https://t.co/HHxiIuc8Jt. Conf call at 1pm, dial 866-834-3313, #2995924. Care\u2026 https://t.co/8VatEh71LK"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "AlloSure sales is overwhelmingly comprised of usage in clinical studies designed to test the product's effectivenes\u2026 https://t.co/9D03EMfLiV"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "Trials show that AlloSure misses &gt;40% of rejections identified by the current standard of care, making it dangerous\u2026 https://t.co/K8cVvozmW9"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "Patient attrition rates are a staggering 25% *per quarter* and new patient enrollment has peaked. This points to de\u2026 https://t.co/GbG1OlkCfe"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "Poor results expose AlloSure to competition in H2. Natera\u2019s Prospera test is set to enter the market, partnering w/\u2026 https://t.co/yRXtwoP8U3"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "Finally, the studies showing AlloSure\u2019s extremely limited clinical utility will affect the parameters of permanent\u2026 https://t.co/1wuUBDYDLR"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "At 18x trailing revenue, and 33x the most recent quarter\u2019s AlloSure run-rate, CareDx\u2019s valuation is even richer tha\u2026 https://t.co/s1JqkRones"}, {"Name": "KerrisdaleCap", "Time": "20190716", "Text": "@AnthonyTsaiPPro Eastern"}, {"Name": "xuexishenghuo", "Time": "20190716", "Text": "2 done, 1 to go https://t.co/9OqOaZt5JS"}, {"Name": "xuexishenghuo", "Time": "20190716", "Text": "@AlderLaneeggs He is the best"}, {"Name": "xuexishenghuo", "Time": "20190716", "Text": "@AlderLaneeggs But but but if you don\u2019t like the idea of predators selling crap to poor people, you could be a racist"}, {"Name": "GrantsPub", "Time": "20190716", "Text": "Almost Daily Grant's 7/16: Float upstream     https://t.co/2SGk5XqIiq https://t.co/lxCtSG0a1x"}]